Agaimy Abbas, Cheng Liang, Egevad Lars, Feyerabend Bernd, Hes Ondřej, Keck Bastian, Pizzolitto Stefano, Sioletic Stefano, Wullich Bernd, Hartmann Arndt
*Institute of Pathology #Department of Urology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital of Erlangen, Erlangen ∥Institute of Pathology, MVZ Hanse Histologikum GMBH, Hamburg, Germany †Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN ‡Department of Oncology-Pathology, Karolinska Institute §Department of Pathology, Karolinska University Hospital, Stockholm, Sweden ¶Sikl's Department of Pathology, Charles University, Medical Faculty Hospital, Pilsen, Czech Republic **Department of Pathology, University Hospital of Udine, Udine, Italy.
Am J Surg Pathol. 2017 Feb;41(2):253-262. doi: 10.1097/PAS.0000000000000787.
Undifferentiated (anaplastic) and rhabdoid cell features are increasingly recognized as adverse prognostic findings in renal cell carcinoma (RCC), but their molecular pathogenesis has not been studied sufficiently. Recent studies identified alterations in the Switch Sucrose nonfermentable (SWI/SNF) chromatin remodeling complex as molecular mechanisms underlying dedifferentiation and rhabdoid features in carcinomas of different organs. We herein have analyzed 32 undifferentiated RCCs having in common an undifferentiated (anaplastic) phenotype, prominent rhabdoid features, or both, irrespective of the presence or absence of conventional RCC component. Cases were stained with 6 SWI/SNF pathway members (SMARCB1, SMARCA2, SMARCA4, ARID1A, SMARCC1, and SMARCC2) in addition to conventional RCC markers. Patients were 20 males and 12 females aged 32 to 85 years (mean, 59). A total of 22/27 patients with known stage presented with ≥pT3. A differentiated component varying from microscopic to major component was detected in 20/32 cases (16 clear cell and 2 cases each chromophobe and papillary RCC). The undifferentiated component varied from rhabdoid dyscohesive cells to large epithelioid to small monotonous anaplastic cells. Variable loss of at least 1 SWI/SNF complex subunit was noted in the undifferentiated/rhabdoid component of 21/32 cases (65%) compared with intact or reduced expression in the differentiated component. A total of 15/17 patients (88%) with follow-up died of metastatic disease (mostly within 1 y). Only 2 patients were disease free at last follow-up (1 and 6 y). No difference in survival, age distribution, or sex was observed between the SWI/SNF-deficient and the SWI/SNF-intact group. This is the first study exploring the role of SWI/SNF deficiency as a potential mechanism underlying undifferentiated and rhabdoid phenotype in RCC. Our results highlight the association between the aggressive rhabdoid phenotype and the SWI/SNF complex deficiency, consistent with studies on similar neoplasms in other organs. Thorough sampling of such tumors that are usually huge and locally advanced is necessary for recognizing the clone of origin and hence for proper subtyping and also for differentiating them from undifferentiated urothelial carcinoma.
未分化(间变性)和横纹肌样细胞特征越来越被认为是肾细胞癌(RCC)预后不良的表现,但它们的分子发病机制尚未得到充分研究。最近的研究发现,开关蔗糖非发酵(SWI/SNF)染色质重塑复合体的改变是不同器官癌去分化和横纹肌样特征的分子机制。我们在此分析了32例未分化RCC,这些病例具有共同的未分化(间变性)表型、显著的横纹肌样特征或两者兼有,无论是否存在传统RCC成分。除了传统的RCC标志物外,还用6种SWI/SNF通路成员(SMARCB1、SMARCA2、SMARCA4、ARID1A、SMARCC1和SMARCC2)对病例进行染色。患者年龄在32至85岁之间(平均59岁),男性20例,女性12例。已知分期的22/27例患者表现为≥pT3。在20/32例病例(16例透明细胞癌,各2例嫌色细胞癌和乳头状RCC)中检测到从微小成分到主要成分不等的分化成分。未分化成分从横纹肌样散在细胞到大型上皮样细胞再到小型单一间变性细胞不等。与分化成分中完整或表达降低相比,在21/32例病例(65%)的未分化/横纹肌样成分中观察到至少1种SWI/SNF复合体亚基的可变缺失。17例有随访的患者中有15例(88%)死于转移性疾病(大多在1年内)。最后随访时只有2例患者无疾病(分别为1年和6年)。SWI/SNF缺陷组和SWI/SNF完整组在生存率、年龄分布或性别方面未观察到差异。这是第一项探索SWI/SNF缺陷作为RCC中未分化和横纹肌样表型潜在机制的研究。我们的结果突出了侵袭性横纹肌样表型与SWI/SNF复合体缺陷之间的关联,这与其他器官类似肿瘤的研究一致。对于这类通常体积巨大且局部进展的肿瘤,进行全面取材对于识别起源克隆、从而进行正确的亚型分类以及将它们与未分化尿路上皮癌区分开来是必要的。